经皮冠状动脉介入治疗在县级医院急性冠脉综合征患者中的应用  

Application of percutaneous coronary intervention in patients with acute coronary syndrome in county-level hospitals

作　　者：汪志强 郑康 Wang Zhiqiang;Zheng Kang(Department of Cardiology,Feng Tai People's Hospital,Huainan 232100,Anhui Province,China)

机构地区：[1]凤台县人民医院心内科,淮南232100

出　　处：《中国基层医药》2023年第7期1066-1069,共4页Chinese Journal of Primary Medicine and Pharmacy

摘　　要：目的研究经皮冠状动脉介入治疗(PCI)在县级医院急性冠脉综合征(ACS)患者中的应用价值。方法回顾性分析凤台县人民医院2020年1月至2022年1月收治的ACS患者51例的临床资料,根据治疗方法的不同分为对照组25例、观察组26例,对照组给予标准双联抗血小板及他汀等药物强化治疗,观察组在常规药物治疗的基础上,行冠状动脉造影及支架植入等PCI。随访1年,比较两组左室射血分数(LVEF)、左室舒张末期内径(LVEDD)等心功能指标,比较两组再住院率、住院总时间、生活质量评分、药物及手术并发症发生情况,观察两组不良心血管事件的发生情况。结果治疗前,两组LVEF、LVEDD差异均无统计学意义(均P > 0.05);治疗后,两组LVEF、LVEDD均改善,观察组LVEF、LVEDD分别为(50.34±5.97)%、(49.01±5.02)mm,均优于对照组的(45.61±5.42)%、(52.12±5.24)mm(t=-2.96、2.17,均P < 0.05)。治疗后,观察组再次住院次数[(0.8±0.1)次]少于对照组[(2.1±0.3)次],住院总时间[(12.4±3.1)d]短于对照组[(25.3±3.9)d],生活质量评分[(85.3±5.9)分]高于对照组[(72.5±5.2)分],差异均有统计学意义(t=20.14、13.10、-8.19,均P < 0.001)。观察组不良心血管事件发生率为3.9%(1/26),低于对照组的28.0%(7/25),差异有统计学意义(χ^(2)=3.94,P=0.041)。结论县级医院ACS患者行PCI切实可行,可显著改善患者心功能,临床疗效显著,不良事件发生率较低。Objective To investigate the application value of percutaneous coronary intervention in patients with acute coronary syndrome in county-level hospitals.Methods The clinical data of 51 patients with acute coronary syndrome who received treatment in Feng Tai People's Hospital from January 2020 to January 2022 were retrospectively analyzed.They were divided into a control group(n=25)and an observation group(n=26).The control group was given standard dual antiplatelet and statin drugs.The observation group underwent percutaneous coronary intervention and stent implantation based on conventional drug treatment.All patients were followed up for 1 year.Cardiac function indexes left ventricular ejection fraction(LVEF)and left ventricular end-diastolic diameter(LVEDD)were compared between the two groups.The number of readmissions,length of hospital stay,quality of life score,medication,the incidence of complications,and the incidence of adverse cardiovascular events were compared between the two groups.Results Before treatment,there were no significant differences in LVEF and LVEDD between the two groups(both P>0.05).After treatment,LVEF was increased,and LVEDD was decreased in each group compared with before treatment.After treatment,LVEF and LVEDD in the observation group were(50.34±5.97)%and(49.01±5.02)mm,respectively,which were significantly superior to(45.61±5.42)%and(52.12±5.24)mm in the control group(t=-2.96,2.17,both P<0.05).After treatment,the number of readmissions in the observation group was significantly less than that in the control group[(0.8±0.1)times vs.(2.1±0.3)times,t=20.14,P<0.001].The length of hospital stay in the observation group was significantly shorter than that in the control group[(12.4±3.1)days vs.(25.3±3.9)days,t=13.10,P<0.001].Quality of life score in the observation group was significantly higher than that in the control group[(85.3±5.9)points vs.(72.5±5.2)points,t=-8.19,P<0.001].After treatment,the incidence of adverse cardiovascular events in the observation group was significa

关 键 词：急性冠状动脉综合征 心血管造影术 经皮冠状动脉介入治疗 心脏功能试验 生活质量 并发症 医院 县 

分 类 号：R541.4[医药卫生—心血管疾病]